Skip to main content
Clinical Trials/ACTRN12609000167268
ACTRN12609000167268CompletedPhase 1

Effects of omega-3 fatty acids high in eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA) vs placebo on cognition and mood in older adults with mild cognitive impairment

utritional Physiology Research Centre0 sites120 target enrollmentStarted: April 3, 2009Last updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Completed
Sponsor
Enrollment
120

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
65 Years to o limit (—)
Sex
All

Inclusion Criteria

  • Mild cognitive impairment (subjective memory loss over past 6 months; Standardised Mini-Mental State Examination (SMMSE) score > 24; Paired Associate Learning (PAL) score < 1.5 standard deviations from population mean and/or Demtect score between 9-12)

Exclusion Criteria

  • Dementia and other neurological conditions, consumption of omega-3 fatty supplements within previous 3 months

Investigators

Sponsor
utritional Physiology Research Centre

Similar Trials